It is speculated that Structural Maintenance of Chromosomes 2 (SMC2), DNA Topoisomerase II Alpha, SMC2, KIF23, and other targets may be involved in the pathogenesis of PAH, and the potential molecular mechanism of PAH provides new evidence. The gene discussed is TOP2A; the disease is pulmonary arterial hypertension.